v3.26.1
Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Class A
Common Stock
Class B
Additional Paid-in Capital
Accumulated Deficit
Total Stockholders’ Equity attributable to Purple Innovation, Inc.
Noncontrolling Interest
Total
Balance at Dec. 31, 2022 $ 9 $ 529,466 $ (355,212) $ 174,263 $ 908 $ 175,171
Balance (in Shares) at Dec. 31, 2022 91,380 448          
Net loss (120,757) (120,757) (458) (121,215)
Stock-based compensation 4,875 4,875 4,875
Exchange of stock
Exchange of stock (in Shares) 243 (243)          
Proportional Representation Preferred Linked Stock redemption fee (105) (105) (105)
Issuance of stock upon underwritten offering, net of costs $ 2 56,997 56,999 56,999
Issuance of stock upon underwritten offering, net of costs (in Shares) 13,400            
Escrow shares cancelled in connection with Intellibed acquisition (118) (118) (118)
Escrow shares cancelled in connection with Intellibed acquisition (in Shares) (41)            
Issuance of stock under equity compensation plans
Issuance of stock under equity compensation plans (in Shares) 525            
Impact of transactions affecting NCI 265 265 (265)
Balance at Dec. 31, 2023 $ 11 591,380 (475,969) 115,422 185 115,607
Balance (in Shares) at Dec. 31, 2023 105,507 205          
Net loss (97,897) (97,897) (201) (98,098)
Issuance of stock for Intellibed acquisition
Issuance of stock for Intellibed acquisition (in Shares) 1,500            
Stock-based compensation 2,815 2,815 2,815
Exchange of stock
Exchange of stock (in Shares) 40 (40)          
Issuance of stock under equity compensation plans (115) (115) (115)
Issuance of stock under equity compensation plans (in Shares) 498            
Impact of transactions affecting NCI (27) (27) 27
Balance at Dec. 31, 2024 $ 11 594,053 (573,866) 20,198 11 20,209
Balance (in Shares) at Dec. 31, 2024 107,545 165          
Net loss (51,414) (51,414) (97) (51,511)
Accrued distributions 85 85 85
Stock-based compensation 1,729 1,729 1,729
Exchange of stock
Exchange of stock (in Shares) 2 (2)          
Issuance of stock under equity compensation plans (181) (181) (181)
Issuance of stock under equity compensation plans (in Shares) 699            
Impact of transactions affecting NCI (104) (104) 104
Balance at Dec. 31, 2025 $ 11 $ 595,582 $ (625,280) $ (29,687) $ 18 $ (29,669)
Balance (in Shares) at Dec. 31, 2025 108,246 163